Učitavanje...
Changes in Use of Disease Modifying Anti-Rheumatic Drugs for Rheumatoid Arthritis in the U.S. for the period 1983–2009
OBJECTIVE: Use of non-biologic disease-modifying antirheumatic drugs (nbDMARD) and/or biologic DMARDs (bDMARD) is generally recommended to improve the prognosis of patients with rheumatoid arthritis (RA). The objective of this study was to describe the changing trends in DMARD use for RA over the pa...
Spremljeno u:
| Glavni autori: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2013
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3717397/ https://ncbi.nlm.nih.gov/pubmed/23463543 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acr.21997 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|